Amicogen

Amicogen, a leading industrial biotechnology company based in Korea, specializes in developing innovative biocatalysts and proteins using proprietary iDNA technology. The company operates in the healthcare, nutrition, and biopharmaceutical sectors, serving clients ranging from healthcare providers to nutrition companies. Amicogen's business model revolves around the research, development, and commercialization of bio-products and new bio-ingredients aimed at improving human health and preserving the environment. Revenue is generated through the sale of these specialized products and through strategic investments and partnerships, including supply agreements and convertible bond takeovers. The company has a strong presence in both local and international markets, including China, and continues to expand its manufacturing capabilities. Amicogen's commitment to innovation and sustainability positions it as a key player in the biotechnology industry.

Keywords: biocatalysts, proteins, iDNA technology, healthcare, nutrition, biopharmaceuticals, bio-products, sustainability, innovation, biotechnology.